期刊文献+

基础胰岛素联合口服降糖药治疗2型糖尿病的治疗方案

下载PDF
导出
摘要 ①二甲双胍与基础胰岛素联合治疗能减轻单用基础胰岛素治疗时的体重增加程度.还可以减少胰岛素用量。②双胍类及TZD类药物在空腹血糖水平较高的患者中与基础胰岛素联用降糖效果较好。③口服降糖药联合基础胰岛素治疗时.必须结合降糖疗效及降糖以外的疗效选择基础胰岛素的种类。
出处 《药品评价》 CAS 2011年第15期56-63,共8页 Drug Evaluation
  • 相关文献

参考文献42

  • 1The Diabetes Control and Complications Trial Research Group. The Effect of Imensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus[J]. N Engl J Med, 1993, 329: 977-986.
  • 2American Diabetes Association: Standards of medical care in diabetes--2008[J]. Diabetes Care, 2008, 31 Suppl 1:S12-54.
  • 3Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes[J]. Diabetes Care, 2009, 32:193-203.
  • 4Barnett A. Dosing of insulin glargine in the treatment of type 2 diabetes[I]. Clin Ther, 2007, 29: 987-999.
  • 5Lepore M, Pampanelli S, Fanelli C, et al. Pbarmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro[J]. Diabetes, 2000, 49: 2142-2148.
  • 6McKeage K, Goa KL. Insulin glargine: a review of its therapeutic use as a longacting agent for the management of type 1 and 2 diabetes mellilus[J]. Drugs, 2001, 61: 1599- 1624.
  • 7Riddle MC, Rosenstock J, Gerich J. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients[J]. Diabetes Care, 2003, 26: 3080-3086.
  • 8Hermansen K, Davies M, Derezinski T, et al. A 26-week, randomized, parallel, treat- to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes[J]. Diabetes Care, 2006, 29: 1269-1274.
  • 9Rosenstock J, Davies M, Home PD, et al. A tandomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose lowering drugs in insulin-naive people with type 2 diabetes[J]. Diabetologia, 2008, 51: 408-416.
  • 10Haffner SM, D'Agostino R, Mykkanen L, et al. Proinstdin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosderosis Study[J]. Stroke, 1998, 29: 1498-1503.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部